CH
REPL icon

CVI Holdings’s Replimune Group REPL Stock Holding History

CVI Holdings’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-186,187
Closed -$4.63M – 113
2020
Q2 		$4.63M Buy
186,187
+127,592
+218% +$2.26M 1.72% 16
2020
Q1 		$584K Sell
58,595
-351,933
-86% -$5.25M 2.05% 14
2019
Q4 		$5.89M Buy
+410,528
New +$5.92M 8.3% 4

Other funds holding REPL

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CVI Holdings's REPL Position: Q3 2020 in Review

CVI Holdings sold out of Replimune Group (REPL) in Q3 2020, closing a stake of 186,187 shares — an estimated $4.63M sold.

CVI Holdings first reported a position in REPL in Q4 2019 and held it in 3 quarters. The position peaked at $5.89M in Q4 2019. 78 funds tracked by Wall St. Rank hold REPL as of Q3 2020.

  • CVI Holdings reported no remaining Replimune Group position as of Q3 2020 after selling out during the quarter.
  • CVI Holdings sold 186,187 Replimune Group shares in Q3 2020, an estimated $4.63M.
  • CVI Holdings first reported a position in Replimune Group in Q4 2019 and held it in 3 quarters.
  • CVI Holdings's Replimune Group position peaked at $5.89M in Q4 2019.
  • 78 funds tracked by Wall St. Rank held Replimune Group as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.